ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

ClinicalTrials.gov ID: NCT05059236

Public ClinicalTrials.gov record NCT05059236. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-label Study of Androgen Receptor Inhibition With dArolutamide Plus Androgen Deprivation Therapy (ADT) Versus ADT in Men With Metastatic Hormone-Sensitive Prostate Cancer Using an External Control Arm

Study identification

NCT ID
NCT05059236
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bayer
Industry
Enrollment
223 participants

Conditions and interventions

Interventions

  • ADT Other
  • Darolutamide (BAY1841788, Nubeqa) Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 3, 2021
Primary completion
May 29, 2025
Completion
Jun 4, 2026
Last update posted
Apr 30, 2026

2021 – 2026

United States locations

U.S. sites
31
U.S. states
19
U.S. cities
27
Facility City State ZIP Site status
Urology Centers of Alabama, PC - Homewood Homewood Alabama 35209
Arizona Urology Specialists - Tucson - W Orange Grove Tucson Arizona 85741
Tower Urology Los Angeles California 90048
UCI Health Center for Urological Care Orange California 92868
UC San Diego Health - Moores Cancer Center San Diego California 92037
Providence Saint John's Cancer Institute Santa Monica California 90404
Brigham and Women's Hospital (BWH) - Surgery Urology Atlanta Georgia 30318
Piedmont Cancer Institute - Atlanta Atlanta Georgia 30318
Northwestern Medicine - Urology Chicago Illinois 60611
Northwestern University's Feinberg School of Medicine Chicago Illinois 60611
UM Greenebaum Comprehensive Cancer Center Baltimore Maryland 21201
Lieutenant Colonel Charles S. Kettles VA Medical Center - Oncology Ann Arbor Michigan 48105
Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit Michigan 48201
Michigan Institute of Urology - Troy - Town Center Building Troy Michigan 48084
AMR - Kansas City Kansas City Missouri 64132
GU Research Network, LLC - Oncology radiology Omaha Nebraska 68130
XCancer Omaha Omaha Nebraska 68130
New Jersey Urology - Clifton Clifton New Jersey 07013
New Jersey Urology - Voorhees Voorhees Township New Jersey 08043
New Mexico Cancer Center - Albuquerque Albuquerque New Mexico 87109
Mount Sinai Doctors - Faculty Practice New York New York 10029
Mount Sinai Faculty Practice Associates New York New York 10029
Associated Medical Professionals of NY Syracuse Syracuse New York 13210
The Urology Group - Norwood Surgery Center Cincinnati Ohio 45212
Columbus Prostate Cancer Center / Radiation Oncology Clinic Gahanna Ohio 43230
MidLantic Urology - Bala Cynwyd Bala-Cynwyd Pennsylvania 19004
Carolina Urological Research Center Myrtle Beach South Carolina 29579
Urology Associates, PC - Nashville Nashville Tennessee 37209
Houston Methodist Research Institute Houston Texas 77030
Inova Schar Cancer Institute (vendor) Fairfax Virginia 22031
Spokane Urology PS Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05059236, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 30, 2026 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05059236 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →